DR. RAVI JAYENDRA CHOKSHI, M.D.

NEWARK, NJ

Research Active
Surgery - Surgical Oncology NPI registered 18+ years 50 publications 2013 – 2026 NPI: 1427210848

Practice Location

185 S ORANGE AVE
NEWARK, NJ 07103-2757

Phone: (973) 972-5714

What does RAVI CHOKSHI research?

Dr. Chokshi studies multiple aspects of cancer care, including the effectiveness of different surgical techniques, costs associated with treatments, and the conditions surrounding diagnosis. He is particularly interested in cancers such as gastric and pancreatic cancer, as well as collected data from diverse patient populations to highlight health disparities in diagnosis and care. His research also explores the roles of advanced procedures, like hemicorporectomy, and innovative diagnostic methods, such as liquid biopsies, to enhance early detection and management of these diseases.

Key findings

  • His study on late-stage cancer presentations at safety net hospitals revealed that treating these patients costs 60-80% more than early-stage treatments, emphasizing the need for better detection methods.
  • Research involving over 1,000 patients found that elevated DNA levels in stomach fluid could serve as a biomarker for gastric cancer, indicating a potential new diagnostic tool.
  • Analysis of bariatric surgery cases showed that Black patients were more likely to face complications due to receiving less access to minimally invasive surgeries, highlighting systemic issues in healthcare access.

Frequently asked questions

Does Dr. Chokshi study gastric cancer?
Yes, he has conducted research on gastric cancer, including diagnostic methods and treatment strategies.
What innovative treatment approaches has Dr. Chokshi researched?
He has investigated the effectiveness and cost-efficiency of various surgical methods, including robotic and laparoscopic techniques for different conditions.
Is Dr. Chokshi's work relevant to patients from underserved communities?
Absolutely, his research highlights disparities in cancer treatment access and outcomes for underserved populations, pushing for improvements in care delivery.

Publications in plain English

The Hidden Costs of Late Presentation of Cancer at Safety Net Hospitals.

2026

The Journal of surgical research

Mehra S, Yang A, Dornbrand-Lo M, Beesam S, Mele A +4 more

Plain English
Safety net hospitals serve over 28 million uninsured or Medicaid-dependent Americans but disproportionately treat patients with late-stage cancers, which cost 60-80% more to treat than early-stage disease. Only 12% of these hospitals hold cancer-related quality accreditations from the American College of Surgeons, largely due to staffing shortages and funding cuts. Expanding accreditation at these hospitals would improve early detection and standardized care for the country's most vulnerable patients.

PubMed

Safety Net Hospitals and the Quality of Surgical Care.

2025

Annals of surgery open : perspectives of surgical history, education, and clinical approaches

Mehra S, Yang A, Dornbrand-Lo M, Beesam S, Mele A +4 more

Plain English
This study found that most of the 322 safety net hospitals in the United States lack American College of Surgeons quality accreditations: only 36% hold cancer care accreditation and just 5% are accredited for rectal cancer programs. Nearly one in five states has no safety net hospital at all, leaving large gaps in access for underserved populations. Pursuing these accreditations would help these hospitals deliver more consistent, guideline-based surgical care to patients who need it most.

PubMed

Redefining the Role of Hemicorporectomy in the Modern Era and Shifting Trends Toward Non-Malignant Indications.

2025

The American surgeon

Greendyk JD, Haider SF, Allen WE, Prasath V, Chokshi RJ

Plain English
This systematic review examined 40 cases of hemicorporectomy—surgical removal of the lower half of the body—performed between 1990 and 2022, a procedure previously reserved almost exclusively for cancer. The most common reasons were now pelvic bone infection and trauma rather than malignancy, and many patients achieved significant recovery milestones including mobility and return to employment. Despite its extreme nature, the procedure can be life-saving for carefully selected patients with no other options.

PubMed

Endoscopic liquid biopsies of gastric fluid in a large human patient cohort reveal DNA content as a candidate tumor biomarker in gastric cancer.

2025

eLife

Cadoná FC, Bartelli TF, Pelosof AG, Sztokfisz CZ, Bueno AP +20 more

Plain English
Researchers analyzed DNA collected from stomach fluid during routine upper endoscopy in over 1,000 patients and found that DNA levels were significantly higher in those with gastric cancer compared to those with benign or precancerous conditions. Higher DNA levels also correlated with more advanced tumors, and paradoxically, patients with elevated levels had longer progression-free survival, possibly because of greater immune cell activity in the tumor. This stomach fluid test could become a useful add-on to standard biopsy for diagnosing and tracking gastric cancer.

PubMed

Cost-effectiveness of staging laparoscopy with peritoneal cytology in pancreatic adenocarcinoma.

2024

Current problems in surgery

Jodidio M, Panse NS, Prasath V, Trivedi R, Arjani S +1 more

PubMed

Locally Advanced Gastric Cancer Management: A Cost-Effectiveness Analysis.

2024

The American surgeon

Prasath V, Quinn PL, Arjani S, Li S, Oliver JB +4 more

Plain English
This cost-effectiveness analysis compared upfront surgery versus perioperative chemotherapy for locally advanced gastric cancer using a decision tree model based on Medicare reimbursement rates. Perioperative chemotherapy was the dominant strategy at $40,792 for 3.11 quality-adjusted life years, while upfront surgery cost nearly $15,000 more while yielding only a marginal gain in quality-adjusted life years — far exceeding standard cost-effectiveness thresholds. Perioperative chemotherapy is the more cost-effective choice for locally advanced gastric cancer in the U.S. healthcare context.

PubMed

Sentinel lymph node biopsy for head and neck cutaneous squamous cell carcinoma using the Brigham and Women's staging system: a cost analysis.

2023

Archives of dermatological research

Quinn PL, Kim JK, Prasath V, Panse N, Knackstedt TJ +1 more

Plain English
This cost-effectiveness analysis evaluated sentinel lymph node biopsy for head and neck skin squamous cell carcinoma staged using the Brigham and Women's Hospital system. The biopsy was cost-effective only for the highest-risk T3 tumors, with an incremental cost-effectiveness ratio of about $18,000, while skipping the biopsy was the dominant strategy for T2a and T2b tumors. Patient selection for this procedure should be individualized based on the specific tumor stage.

PubMed

Pleomorphic Rhabdomyosarcoma: A Systematic Review with Outcome Analysis and Report of a Rare Abdominal Wall Lesion.

2023

International journal of surgical pathology

Deb PQ, Chokshi RJ, Li S, Suster DI

Plain English
This study analyzed 242 cases of pleomorphic rhabdomyosarcoma—a rare and aggressive muscle-tissue cancer—from a national cancer database and found that age at diagnosis, tumor stage, and whether surgery was performed significantly affected survival, while race, sex, and tumor location did not. Only five prior cases of this tumor arising from the abdominal wall had been reported in the literature. These findings help clarify which patient and tumor factors drive outcomes in this poorly understood malignancy.

PubMed

Perineal reconstruction after radical pelvic surgery: A cost-effectiveness analysis.

2023

Surgery

Prasath V, Naides AI, Weisberger JS, Quinn PL, Ayyala HS +3 more

Plain English
This cost-effectiveness analysis compared four methods of reconstructing the perineum after radical pelvic surgery: primary closure, and three flap techniques. The gluteal thigh flap provided the best quality of life at the lowest overall cost, with an incremental cost-effectiveness ratio of about $5,600, making it the dominant strategy in nearly all scenarios. Surgeons should use the gluteal thigh flap as their first choice when it is technically feasible.

PubMed

Neoadjuvant Treatment Versus Upfront Surgery in Resectable Pancreatic Cancer: A Cost-Effectiveness Analysis.

2023

JCO oncology practice

Arjani S, Prasath V, Suri N, Li S, Ahlawat S +1 more

Plain English
A decision-tree model evaluated whether giving chemotherapy and radiation before surgery is more cost-effective than going straight to surgery for resectable pancreatic cancer. Neoadjuvant chemoradiation cost about $45,500 and yielded more quality-adjusted life years, with an incremental cost-effectiveness ratio of roughly $48,000—well within accepted thresholds—and was favored in 94% of simulations. Preoperative chemoradiation should be the default approach unless there is a specific contraindication.

PubMed

Cost-effectiveness analysis of robotic cholecystectomy in the treatment of benign gallbladder disease.

2023

Surgery

Singh A, Panse NS, Prasath V, Arjani S, Chokshi RJ

Plain English
This decision-tree analysis compared the costs and outcomes of robotic versus laparoscopic cholecystectomy for gallbladder disease using Medicare reimbursement data. Robotic surgery cost about $3,000 more while adding only a negligible quality-of-life benefit, producing an incremental cost-effectiveness ratio of nearly $1.8 million per quality-adjusted life year—far exceeding accepted thresholds. Standard laparoscopic cholecystectomy remains the more cost-effective treatment for the vast majority of patients.

PubMed

Escape from oncogene-induced senescence is controlled by POU2F2 and memorized by chromatin scars.

2023

Cell genomics

Martínez-Zamudio RI, Stefa A, Nabuco Leva Ferreira Freitas JA, Vasilopoulos T, Simpson M +6 more

Plain English
This study uncovered how cancer cells escape a natural anti-tumor defense called oncogene-induced senescence, a dormant state that normally halts abnormal cell growth. The transcription factor POU2F2 drives this escape by activating a precoded set of gene enhancers, and its elevated activity was detected in precancerous colon lesions and associated with worse patient survival. POU2F2 and associated chromatin signatures may serve as early diagnostic and prognostic biomarkers in colorectal cancer.

PubMed

The Mediating Effect of Operative Approach on Racial Disparities in Bariatric Surgery Complications.

2023

The Journal of surgical research

Matabele MM, Haider SF, Wood Matabele KL, Merchant AM, Chokshi RJ

Plain English
Analyzing over 150,000 bariatric surgery cases, this study found that Black patients were significantly more likely to receive open rather than minimally invasive surgery for both gastric bypass and sleeve gastrectomy, and they experienced higher rates of complications and unplanned readmissions. For gastric bypass, reduced access to the laparoscopic approach partially explained the racial gap in complications. These findings point to systemic barriers upstream of the operating room that drive unequal surgical outcomes.

PubMed

Economic evaluation of robotic and laparoscopic paraesophageal hernia repair.

2023

Surgical endoscopy

Panse NS, Prasath V, Quinn PL, Chokshi RJ

Plain English
A cost-effectiveness model compared robotic versus laparoscopic repair of paraesophageal hernias using Medicare cost data and found that robotic repair costs about $500 more while providing almost no additional benefit, yielding an incremental cost-effectiveness ratio of roughly $779,000 per quality-adjusted life year. Laparoscopic repair was favored in every sensitivity analysis and 100% of simulations. Robotic hernia repair is not cost-effective at most institutions unless surgeons have already surpassed the learning curve and capital costs are excluded.

PubMed

Colon cancer epidemiology, race and socioeconomic status: Comparing trends in counties served by an urban hospital in Newark, NJ with overall NJ-state and nation-wide patterns.

2023

Cancer epidemiology

Selvakumar T, Mu SZ, Prasath V, Arjani S, Chokshi RJ +1 more

Plain English
This study characterized colon cancer trends at a Newark, NJ hospital serving a predominantly Black and Hispanic population and found higher rates of both late-stage and early-onset diagnoses compared to state and national averages. Across New Jersey, Black, Hispanic, and Asian/Pacific Islander patients had significantly greater odds of being diagnosed with advanced or young-onset colon cancer compared to White patients, and counties with greater social vulnerability had higher colorectal cancer death rates. These findings highlight where targeted screening and access interventions are most needed.

PubMed

Racial disparities in minimally invasive esophagectomy and gastrectomy for upper GI malignancies.

2022

Surgical endoscopy

Haider SF, Ma S, Xia W, Wood KL, Matabele MM +3 more

Plain English
This analysis of nearly 13,000 esophageal and gastric cancer surgeries found that Black patients were significantly more likely to undergo open gastrectomy rather than minimally invasive surgery, and Black patients undergoing esophagectomy had higher rates of complications, severe complications, and 30-day mortality regardless of surgical approach. These disparities were independent of other patient factors, pointing to structural inequities in access to advanced surgical techniques. The findings call for targeted efforts to identify and remove the barriers preventing minority patients from receiving minimally invasive care.

PubMed

Endoscopic Versus Laparoscopic Drainage of Pancreatic Pseudocysts: a Cost-effectiveness Analysis.

2022

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract

Quinn PL, Bansal S, Gallagher A, Chokshi RJ

Plain English
A decision-tree analysis compared endoscopic and laparoscopic drainage of symptomatic pancreatic pseudocysts. Endoscopic drainage was the dominant strategy, producing better outcomes while saving nearly $24,000 per patient compared to laparoscopic drainage, with results confirmed across all sensitivity analyses. Endoscopic drainage should be the first-line treatment for pancreatic pseudocysts when both approaches are available.

PubMed

Cost-effectiveness of adrenal vein sampling- vs computed tomography-guided adrenalectomy for unilateral adrenaloma in primary aldosteronism.

2022

Journal of endocrinological investigation

Arjani S, Bostonian TJ, Prasath V, Quinn PL, Chokshi RJ

Plain English
This cost-effectiveness model compared two strategies for guiding adrenal gland removal in primary aldosteronism: using adrenal vein sampling to confirm which gland is overactive versus relying on CT scan alone. Adrenal vein sampling cost only $308 more but yielded 0.78 additional quality-adjusted life years, giving an incremental cost-effectiveness ratio of under $400. The findings strongly support using adrenal vein sampling as the standard approach before adrenalectomy.

PubMed

Staging CT and Diagnostic Laparoscopy With Cytology Prior to the Treatment of Pancreatic Adenocarcinoma: A Case Series.

2022

Cureus

Panse NS, Prasath V, Arjani S, Quinn PL, Trivedi R +1 more

Plain English
This small case series examined staging laparoscopy with peritoneal fluid testing in eight patients with non-metastatic pancreatic cancer before starting treatment. One patient with positive cytology avoided unnecessary surgery, while those with negative cytology who did not receive timely chemotherapy had very poor survival. The findings suggest peritoneal cytology can help spare some patients from futile operations, but prompt systemic treatment after staging remains critical.

PubMed

Cost-effectiveness analysis of infected necrotizing pancreatitis management in an academic setting.

2022

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

Prasath V, Quinn PL, Oliver JB, Arjani S, Ahlawat SK +1 more

Plain English
This cost-effectiveness analysis compared three management strategies for infected necrotizing pancreatitis — open surgery, endoscopic step-up, and minimally invasive surgical step-up — using a decision tree model with Medicare costs. Endoscopic step-up was the dominant strategy, delivering the most quality-adjusted life years at the lowest cost, with 65.5% of simulations favoring it. The analysis supports endoscopic step-up as the standard approach for infected necrotizing pancreatitis at centers with the necessary expertise.

PubMed

Cost-effectiveness of palliative emergent surgery versus endoscopic stenting for acute malignant colonic obstruction.

2021

Surgical endoscopy

Quinn PL, Arjani S, Ahlawat SK, Chokshi RJ

Plain English
This decision-tree analysis compared endoscopic stent placement versus emergency surgery for patients with bowel obstruction from advanced colorectal cancer. Stenting cost about $5,900 less while yielding more quality-adjusted life years, making it the dominant palliative strategy and favored in over 96% of simulations. Emergency surgery should only be preferred if stenting reintervention rates are very high or if surgical survival improves substantially.

PubMed

Preablation Diagnostic Whole-Body Scan vs Empiric Radioactive Iodine Ablation in Differentiated Thyroid Cancer: Cost-effectiveness Analysis.

2021

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery

Arjani S, Quinn PL, Chokshi RJ

Plain English
A cost-effectiveness model compared two approaches to administering radioactive iodine after thyroid surgery: using a diagnostic whole-body scan to guide the dose versus giving a standard empiric dose. Empiric dosing produced nearly one additional quality-adjusted life year while costing $1,250 less, making it the dominant strategy in virtually all scenarios. For most patients with differentiated thyroid cancer, a pre-ablation diagnostic scan adds cost without improving outcomes.

PubMed

Pancreatic Carcinosarcoma Clinical Outcome Analysis of the National Cancer Institute Database.

2021

The Journal of surgical research

Alhatem A, Quinn PL, Xia W, Chokshi RJ

Plain English
Researchers analyzed 39 cases of pancreatic carcinosarcoma—a rare tumor combining features of both carcinoma and sarcoma—from a national database spanning over four decades. Metastatic disease was the only factor that independently predicted worse survival, while surgery improved outcomes in patients with localized disease. The rarity and aggressiveness of this cancer argue for reserving surgery for localized cases and pursuing novel therapies for advanced disease.

PubMed

Long-Term Recurrence of Retroperitoneal Dedifferentiated Liposarcoma After a Complete Surgical Resection: A Report of a Rare Phenomenon.

2021

Cureus

Patel S, Alhatem A, Patel JS, Zhang R, Chokshi RJ

Plain English
This case report describes a patient whose retroperitoneal liposarcoma recurred 20 years after what appeared to be a complete surgical removal, with different microscopic features at recurrence than at the original diagnosis. Molecular testing confirmed the diagnosis through MDM2 amplification and CDK4 positivity. The case illustrates that even aggressive fat-cell tumors can lie dormant for decades and underscores the need for very long-term surveillance after resection.

PubMed

"Do-not-resuscitate (DNR)" status determines mortality in patients with COVID-19.

2021

Clinics in dermatology

Alhatem A, Spruijt O, Heller DS, Chokshi RJ, Schwartz RA +1 more

Plain English
This study of 1,270 COVID-19 patients admitted to two New Jersey hospitals found that patients who died were far more likely to have had a do-not-resuscitate order at admission than survivors. Patients with DNR orders had more than twice the hazard of dying, a relationship that held after adjusting for other risk factors. DNR status was a strong and independent predictor of mortality during the early COVID-19 pandemic.

PubMed

Management of Solid Pseudopapillary Tumors of the Pancreas: Experience from a Single Institution.

2020

The American surgeon

Kim JK, Dave N, Chokshi RJ

PubMed

Treatment of Rare and Aggressive Pancreatic Carcinosarcoma.

2020

ACG case reports journal

Quinn PL, Ohioma D, Jones AMK, Ahlawat SK, Chokshi RJ

Plain English
This case report describes a 42-year-old woman diagnosed with pancreatic carcinosarcoma—a rare tumor type combining carcinoma and sarcoma—who underwent extensive surgery removing part of the pancreas, spleen, colon, and adrenal gland. Pathology and immunostaining confirmed the rare diagnosis. Despite aggressive resection followed by 20 cycles of chemotherapy, the disease progressed and the patient transitioned to comfort care at 16 months.

PubMed

Correction to: Treatment of Rare and Aggressive Pancreatic Carcinosarcoma.

2020

ACG case reports journal

Quinn PL, Alhatem A, Ohioma D, Jones A, Ahlawat SK +1 more

Plain English
This is a published correction to an earlier article on pancreatic carcinosarcoma treatment and contains no independent scientific content.

PubMed

Impact of insurance status on overall survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC).

2020

Pleura and peritoneum

Chokshi RJ, Kim JK, Patel J, Oliver JB, Mahmoud O

Plain English
This single-institution retrospective study examined whether insurance status affected survival after cytoreductive surgery plus heated intraperitoneal chemotherapy (CRS-HIPEC) for peritoneal cancers in a safety-net hospital context. In 31 patients, statistical analysis found no significant survival difference between insured and underinsured patients, but all six long-term survivors were in the insured group while none were in the underinsured group. The small sample limits conclusions, but the trend suggests insurance disparities may affect long-term outcomes after this aggressive cancer treatment.

PubMed

Cost-Effectiveness of Sentinel Lymph Node Biopsy for Head and Neck Cutaneous Squamous Cell Carcinoma.

2019

The Journal of surgical research

Quinn PL, Oliver JB, Mahmoud OM, Chokshi RJ

Plain English
A cost-effectiveness model evaluated sentinel lymph node biopsy for head and neck skin squamous cell carcinoma across all tumor stages. Skipping the biopsy was the more cost-effective strategy at every stage, primarily because the overall rate of lymph node spread and disease-specific death in this cancer type is low. The procedure should not be performed routinely, regardless of tumor stage.

PubMed

Design of an immunohistochemistry biomarker panel for diagnosis of pancreatic adenocarcinoma.

2019

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

Burnett AS, Quinn PL, Ajibade DV, Peters SR, Ahlawat SK +2 more

Plain English
This proof-of-concept study tested a panel of four protein stains on pancreatic tissue from 27 surgical specimens to improve diagnosis of pancreatic cancer. When three of the markers (VHL, IMP3, and S100A4) were combined into a panel, the test correctly identified cancer with 100% sensitivity and 96% specificity. This biomarker panel warrants prospective testing on biopsy specimens to see if it can improve pre-surgical diagnosis.

PubMed

Multiple Thick Nodular Melanoma: Differentiating Multiple Primaries from the Metastasis of a Previous Single Melanoma.

2019

Balkan medical journal

Alhatem A, Lambert WC, Schwartz RA, Chokshi RJ

PubMed

Malignant Granular Cell Tumor of the Bile Duct.

2019

ACG case reports journal

Quinn PL, Abdelfatah E, Galan MA, Ahlawat SK, Chokshi RJ

Plain English
This case report describes a 56-year-old man who presented with painless jaundice caused by a malignant granular cell tumor obstructing the bile duct—an extremely rare diagnosis. The tumor was identified through endoscopy and confirmed by biopsy before surgical removal. Granular cell tumors of the bile duct are so uncommon that this case adds meaningful detail to the small body of literature on their malignant behavior.

PubMed

Abdominal wall reconstruction after cytoreduction surgery-hyperthermic intraperitoneal chemotherapy.

2018

The Journal of surgical research

Scholer AJ, Oliver JB, Rosado J, Patel JS, Lynch LJ +3 more

Plain English
This retrospective study assessed whether adding abdominal wall reconstruction to cytoreductive surgery and heated intraperitoneal chemotherapy increased postoperative risk. Patients who needed abdominal wall repair had longer operations and greater blood loss, but overall survival and serious complication rates were similar to those who did not require reconstruction. Abdominal wall reconstruction can be safely combined with this complex cancer surgery in appropriately selected patients.

PubMed

Herman Boerhaave, the Dutch Hippocrates, a Forgotten Father of Medicine.

2018

The American surgeon

Scholer AJ, Khan MA, Tandon A, Swan K, Chokshi RJ

Plain English
This historical piece profiles Herman Boerhaave, an 18th-century Dutch physician whose contributions to clinical medicine and medical education transformed how doctors examine and treat patients. Best known today only for the esophageal rupture syndrome bearing his name, Boerhaave's broader influence on bedside teaching and systematic diagnosis is largely forgotten. The article argues that medical educators should reintroduce students to his foundational contributions.

PubMed

Dissecting malpractice in pancreaticoduodenectomy cases.

2017

The Journal of surgical research

Anandalwar SP, Scholer AJ, Ninan G, Oliver JB, Christian D +2 more

Plain English
This analysis of 19 malpractice cases involving pancreaticoduodenectomy—a complex abdominal operation—found that the most common allegation was that the surgery was unnecessary, followed by postoperative negligence and misdiagnosis. Physicians prevailed in 68% of cases, but plaintiff awards when they lost averaged over $4 million. Improving surgeon-patient communication and transparency about operative indications and risks is the most actionable step to reduce litigation.

PubMed

Improving cancer patient emergency room utilization: A New Jersey state assessment.

2017

Cancer epidemiology

Scholer AJ, Mahmoud OM, Ghosh D, Schwartzman J, Farooq M +4 more

Plain English
This study examined over 37,000 cancer-related emergency department visits in New Jersey and found that race, insurance type, age, and cancer type all significantly influenced whether patients were admitted, transferred, or readmitted. Black and Hispanic patients were less likely to be admitted from the ED and had lower readmission rates, a pattern that may reflect barriers to ongoing outpatient care. The authors identify patient navigation, symptom monitoring tools, and standardized care pathways as practical strategies to reduce unnecessary ED visits.

PubMed

A Review of the Long-Term Oncologic Outcomes of Robotic Surgery Versus Laparoscopic Surgery for Colorectal Cancer.

2016

The Indian journal of surgery

Wilder FG, Burnett A, Oliver J, Demyen MF, Chokshi RJ

Plain English
This meta-analysis of five studies compared robotic and laparoscopic surgery for colorectal cancer and found equivalent overall and disease-free survival between the two approaches. Laparoscopic surgery had a modest advantage in operative time, margin length, and lymph node yield, while the two approaches were otherwise comparable. Larger prospective trials are needed to determine whether either approach offers a meaningful long-term oncologic advantage.

PubMed

Giant Basal Cell Carcinoma of the Scalp.

2016

Eplasty

Tandon A, Therattil PJ, Lee ES, Chokshi RJ

PubMed

Erratum to: A Review of the Long-Term Oncologic Outcomes of Robotic Surgery Versus Laparoscopic Surgery for Colorectal Cancer.

2016

The Indian journal of surgery

Wilder FG, Burnett A, Oliver J, Demyen MF, Chokshi RJ

Plain English
This is a published correction to an earlier review article on robotic versus laparoscopic colorectal surgery and contains no independent scientific content.

PubMed

Colorectal Cancer Disparities at an Urban Tertiary Care Center.

2016

The American surgeon

Oliver JB, Son JY, Bongu A, Anandalwar SP, Chokshi RJ

PubMed

Cost-effectiveness of the evaluation of a suspicious biliary stricture.

2015

The Journal of surgical research

Oliver JB, Burnett AS, Ahlawat S, Chokshi RJ

Plain English
A decision-tree model compared three strategies for evaluating a bile duct narrowing without an obvious mass: endoscopic retrograde cholangiopancreatography with brushings, endoscopic ultrasound with needle biopsy, or immediate surgery. Both endoscopic approaches were more cost-effective than surgery, and endoscopic ultrasound was the most cost-effective option in the base case, though the best choice between the two endoscopic approaches depends on institutional expertise. Patients with biliary strictures should undergo investigation before any surgical intervention.

PubMed

Malpractice in colorectal surgery: a review of 122 medicolegal cases.

2015

The Journal of surgical research

Gordhan CG, Anandalwar SP, Son J, Ninan GK, Chokshi RJ

Plain English
This review of 122 colorectal surgery malpractice cases found that the most common allegation was failure to recognize a complication in time, followed by damage to surrounding tissue, with physicians winning about two-thirds of cases. Plaintiff jury awards were significantly larger than settlement payments. Understanding which failures most commonly lead to litigation can help surgeons prioritize communication, documentation, and early complication recognition.

PubMed

Back-to-Front Hemicorporectomy With Double-barreled Wet Colostomy for Treatment of Squamous Cell Carcinoma of a Pressure Ulcer.

2015

The American surgeon

Crum RW, Lee ES, Patterson FR, Chaudhary SB, Baranski GM +1 more

PubMed

Litigation in laparoscopic cholecystectomies.

2014

The American surgeon

Anandalwar SP, Choudhry AJ, Choudhry AJ, Svider PF, Van Luven C +3 more

PubMed

Sensitivity of alternative testing for pancreaticobiliary cancer: a 10-y review of the literature.

2014

The Journal of surgical research

Burnett AS, Bailey J, Oliver JB, Ahlawat S, Chokshi RJ

Plain English
This systematic review analyzed 77 studies published over a decade to compare the accuracy of various tests for diagnosing cancers of the bile duct and pancreas. Standard endoscopic brushing had only 42% sensitivity, but a panel combining the protein stain IMP3 with the marker KOC, S100A4, and standard cytology achieved sensitivities and specificities above 85%. The review provides a practical roadmap for building a more accurate diagnostic panel for these difficult-to-detect cancers.

PubMed

Esophageal perforation and rupture: a comprehensive medicolegal examination of 59 jury verdicts and settlements.

2013

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract

Svider PF, Pashkova AA, Vidal GP, Mauro AC, Eloy JA +1 more

Plain English
An analysis of 59 jury verdicts and settlements involving esophageal perforation found that gastroenterologists, general surgeons, and anesthesiologists were the most commonly named defendants, with two-thirds of cases decided in the physician's favor. Delayed diagnosis and the need for surgical repair were the most common factors in cases resulting in payment, with median plaintiff awards of $1.2 million. Explicitly listing esophageal perforation in informed consent for relevant procedures is a straightforward step to reduce litigation exposure.

PubMed

Sensitivity of endoscopic retrograde cholangiopancreatography standard cytology: 10-y review of the literature.

2013

The Journal of surgical research

Burnett AS, Calvert TJ, Chokshi RJ

Plain English
This 10-year literature review pooled data from 16 studies to determine how accurately standard endoscopic brushing detects bile duct and pancreatic cancers. The combined sensitivity was only 42%, meaning more than half of cancers would be missed by this test alone. The findings question the value of relying on endoscopic brushings to guide surgical decisions when clinical and imaging findings already strongly suggest malignancy.

PubMed

Uncovering malpractice in appendectomies: a review of 234 cases.

2013

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract

Choudhry AJ, Anandalwar SP, Choudhry AJ, Svider PF, Oliver JO +2 more

Plain English
This study analyzed 234 malpractice cases related to appendicitis and appendectomy and found that delayed diagnosis was by far the most common allegation, cited in 67% of cases, with physicians winning about 60% of verdicts. Average plaintiff awards exceeded $794,000, while settlements averaged more than $1.4 million. Prompt evaluation, efficient cross-specialty communication, and thorough informed consent are the most important steps to reduce liability in appendicitis care.

PubMed

Locally aggressive and multicentric recurrent extraocular sebaceous carcinoma: case report and literature review.

2013

Eplasty

Bongu A, Lee ES, Peters SR, Chokshi RJ

Plain English
Doctors treated a rare and dangerous skin cancer called sebaceous carcinoma that kept coming back in multiple spots on a patient's body and spreading aggressively; they removed the main tumor and used a surgical flap to cover the large wound it left behind. The cancer in this patient was particularly aggressive because of a combination of factors: the patient's genetics made them more susceptible to the disease, there was a delay in getting definitive treatment, and the cancer itself is inherently aggressive by nature. This case matters because sebaceous carcinoma is so rare that doctors don't fully understand why it sometimes behaves so aggressively and comes back repeatedly, and studying real-world cases like this one helps doctors recognize the warning signs and treat it more effectively.

PubMed

Frequent Co-Authors

Patrick L Quinn Vishnu Prasath Simran Arjani Joseph B Oliver Sushil K Ahlawat Albert Alhatem Seema P Anandalwar Sharon Li Neal S Panse Sushil Ahlawat

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.